Cargando…

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD

OBJECTIVES: Patients with inflammatory rheumatic diseases (IRD) infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be at risk to develop a severe course of COVID-19. The influence of immunomodulating drugs on the course of COVID-19 is unknown. To gather knowledge about SA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasseli, Rebecca, Mueller-Ladner, Ulf, Schmeiser, Tim, Hoyer, Bimba F, Krause, Andreas, Lorenz, Hanns-Martin, Regierer, Anne Constanze, Richter, Jutta G, Strangfeld, Anja, Voll, Reinhard E, Pfeil, Alexander, Schulze-Koops, Hendrik, Specker, Christof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Miscellaneous
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507994/ https://www.ncbi.nlm.nih.gov/pubmed/32878994 http://dx.doi.org/10.1136/rmdopen-2020-001332

Ejemplares similares

TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD
por: Regierer, Anne Constanze, et al.
Publicado: (2021)

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases
por: Hasseli, Rebecca, et al.
Publicado: (2023)

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases
por: Hasseli, Rebecca, et al.
Publicado: (2021)

Deutsches Register www.Covid19-Rheuma.de: Statusbericht nach 1 Jahr der Pandemie
por: Hasseli, Rebecca, et al.
Publicado: (2021)

Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination
por: Specker, Christof, et al.
Publicado: (2021)

Challenges, facilitators and barriers to the adoption and use of a web-based national IRD registry: lessons learned from the IRD-PT registry
por: Marques, João Pedro, et al.
Publicado: (2022)

Aktualisierte Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit entzündlich-rheumatischen Erkrankungen im Rahmen der SARS-CoV‑2/COVID‑19-Pandemie einschließlich Empfehlungen zur COVID‑19-Impfung
por: Specker, Christof, et al.
Publicado: (2021)

SARS-CoV-2 & Rheuma: Konsequenzen der SARS-CoV-2-Pandemie für Patienten mit entzündlich rheumatischen Erkrankungen. Ein Vergleich der Handlungsempfehlungen rheumatologischer Fachgesellschaften und Risikobewertung verschiedener antirheumatischer Therapien
por: Leipe, J., et al.
Publicado: (2020)

Aktueller Stand der Impfung gegen SARS-CoV-2
por: Iking-Konert, Christof, et al.
Publicado: (2021)

Reactive arthritis after SARS-CoV-2 infection
por: Dombret, Sophia, et al.
Publicado: (2022)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
por: Schulze-Koops, Hendrik, et al.
Publicado: (2021)

Impfung gegen SARS-CoV-2 bei entzündlich rheumatischen Erkrankungen: Empfehlungen der DGRh für Ärzte und Patienten
por: Specker, C., et al.
Publicado: (2021)

The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
por: Hemmat, Nima, et al.
Publicado: (2021)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
por: Lv, Huibin, et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
por: Lv, Huibin, et al.
Publicado: (2020)

Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Ljung, Rickard, et al.
Publicado: (2022)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu, Tong, et al.
Publicado: (2021)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
por: Khaswal, Ashutosh, et al.
Publicado: (2022)

Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
por: Alsafi, Radi Taha
Publicado: (2022)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV
por: Shahbaz, Shima, et al.
Publicado: (2023)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection
por: Zhou, Nan, et al.
Publicado: (2021)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
por: Abdelghany, T.M., et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Propofol and SARS-CoV-2 infection
por: Hirota, Kazuyoshi, et al.
Publicado: (2020)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

SARS-CoV-2 infection in children
por: Çokuğraş, Haluk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fo4384hpgh6o3kdvs5kne9ukjg